Biotech · Private company
Zosano Pharma Corporation
Track this companyFree. Adds Zosano Pharma Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- C213 Microneedle SystemPhase 3 · Cluster HeadacheClinicalTrials.gov · fetched Nov 12, 2026
- M207 Microneedle SystemPhase 3 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- A: M207 3.8mg, 30 min, upper armPhase 1 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- B: M207 3.8 mg, 30 min, thighPhase 1 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- C: M207 3.8 mg, 1 hr, upper armPhase 1 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- D:zolmitriptan nasal sprayPhase 1 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- M207 3.8 mg "MACAP" (two 1.9 mg patches made on a "MACAP" coater, foil cups)Phase 1 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- M207 3.8 mg "MiniMac" (two 1.9 mg patches made on a "MiniMac" coater, foil cupsPhase 1 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- M207 3.8 mg "Sled" (two 1.9 mg patches made on a "Sled" coater, foil pouches)Phase 1 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- Treatment A: M207 3.8 mg "MiniMac"Phase 1 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- Treatment B: M207 3.8 mg "MACAP"Phase 1 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- Treatment C: 5.0 mg Intranasal Zolmitriptan administered at time = 0 and 2 hours post time 0Phase 1 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- Zolmitriptan 2.5 mg/0.1 mL nasal spray [ZOMIG] single dosePhase 1 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study of PK, Safety, and Tolerability of 2 Lots of M207 & Intranasal Zolmitriptan in Healthy VolunteersPHASE1 · COMPLETED · started Jun 24, 2021ClinicalTrials.gov NCT04969497 · fetched Nov 12, 2026
- Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster HeadachesPHASE2_PHASE3 · COMPLETED · started Oct 3, 2019ClinicalTrials.gov NCT04066023 · fetched Nov 12, 2026
- A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy VolunteersPHASE1 · COMPLETED · started May 29, 2019ClinicalTrials.gov NCT03978403 · fetched Nov 12, 2026
- A Study of M207 With Intranasal Zolmitriptan in Healthy VolunteersPHASE1 · COMPLETED · started Nov 1, 2018ClinicalTrials.gov NCT03708744 · fetched Nov 12, 2026
- A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of MigrainePHASE3 · COMPLETED · started Nov 7, 2017ClinicalTrials.gov NCT03282227 · fetched Nov 12, 2026